- Home/
- Article /
- Is basiliximab induction, a novel risk factor for new onset diabetes after transplantation for living donor renal allograft recipients?
Full Author : ['Prasad, Narayan', 'Gurjer, Desraj', 'Bhadauria, Dharmender', 'Gupta, Amit', 'Srivastava, Aneesh', 'Kaul, Anupama', 'Jaiswal, Akhilesh', 'Yadav, Brijesh', 'Yadav, Subhash', 'Sharma, Raj K']
Journal Title : Nephrology (Carlton, Vic.)
Chapter : Section3
Journal Year : 2014
Cited by : Not Available
AIM: It was found that, by affecting populations of T lymphocytes and regulatory T cells, basiliximab also indirectly affects pancreatic beta-cell function and glucose homeostasis. METHODS: In this prospective observational study, we included all renal tr.....
Keywords : ["live donor renal allograft recipient", "novel risk factor", "new onset diabetes", "basiliximab induction", "transplantation"]